Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor (005380) – Provisional Sales Performance for February 2026 and Jan–Feb 2026

Posted on March 3, 2026July 23, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor (005380) – Provisional Sales Performance for February 2026 and Jan–Feb 2026

Fact Source: Financial Supervisory Service DART / 2026-03-03

Disclosure Type: Earnings Release (Provisional) (Fair Disclosure)

💡 3-Second Summary

Hyundai Motor reported total global sales of 306,528 units in February 2026, down 5.1% YoY, while cumulative sales for Jan–Feb 2026 reached 615,088 units, down 3.0% YoY.

📊 1. [Key Disclosure Content & Summary of Figures]

  • Performance Period: Provisional vehicle sales figures for February 2026 and cumulative Jan–Feb 2026

[Monthly Sales Figures: February 2026]

  • Total Sales: 306,528 units (-0.7% MoM, -5.1% YoY)
  • Domestic Sales: 47,008 units (-6.4% MoM, -17.8% YoY)
  • Overseas Sales: 259,520 units (+0.5% MoM, -2.3% YoY)

[Cumulative Sales Figures: Jan–Feb 2026]

  • Total Cumulative Sales: 615,088 units (-3.0% YoY)
  • Domestic Cumulative Sales: 97,216 units (-5.9% YoY)
  • Overseas Cumulative Sales: 517,872 units (-2.4% YoY)
  • Other Notes: Financial metrics (Revenue, Operating Profit, Net Income) are not included in this filing text, which focuses strictly on provisional vehicle unit sales.

📈 2. [Expert Perspective: What This Filing Means for Investors]

This fair disclosure filing provides Hyundai Motor’s vehicle unit sales for February 2026 and the cumulative Jan–Feb 2026 period. The disclosure text contains unit sales figures only and does not include financial figures such as revenue or operating profit, nor qualitative descriptions of performance drivers.

Total February sales declined by 0.7% month-over-month and 5.1% year-over-year, while cumulative Jan–Feb sales decreased by 3.0% year-over-year. Investors will need to track future quarterly financial result disclosures to evaluate the actual financial impact.

📝 Editor’s Comment (by K-STOCK Editor)

This announcement details official sales unit volume data for February and the Jan–Feb 2026 period. Because the filing text is limited to unit volume statistics without revenue or profit data, analysis remains focused on the presented figures.

Investors may review the monthly and cumulative unit sales figures across domestic and overseas markets, while awaiting official financial disclosures to examine how unit volume changes correspond to actual revenue and operating profit performance.

📢 Disclaimer & Source Notice

Source: This content was newly generated and structured based on official submission data from the Financial Supervisory Service DART.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Alteogen (196170) Reports FY2025 Operating Profit of KRW 106.9B, Surging 320.8% YoY
Next Post: [Disclosure] Hanmi Semiconductor (042700) Hits J.P. Morgan Conference! Unveils ‘Hybrid Bonder’ & Aerospace EMI Shield Roadmaps to Global Whales

Related Posts

[Disclosure] Alteogen(196170) to Host Corporate Briefing(IR) for Domestic and Foreign Analysts in Yeouido on November 12 Disclosures
[Disclosure] Hanwha Aerospace (012450) Finalizes Capital Increase Timeline, Amends Share Volume and Ratios Following Third-Party Payment Disclosures
[Disclosure] Hanamicron(067310) Approves Financial Statements and Dividend (50 KRW per share) at AGM Semiconductors
[Disclosure] Alteogen (196170) Designated as Short-Selling Overheated Stock; Short-Selling Banned on May 19 Disclosures
[Disclosure] Samsung Biologics (207940) Extends Non-Disclosure Deadline to 2033 for CMO Contract Disclosures
[Disclosure] SAMSUNG BIOLOGICS(207940) Trading Briefly Suspended and Resumed on May 22 Following Major Corporate Split Announcement Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme